Zhenyu Yan

Bufang Yang, Lixing He, Neiwen Ling et al.

Deep Learning (DL) models have been widely deployed on IoT devices with the help of advancements in DL algorithms and chips. However, the limited resources of edge devices make these on-device DL models hard to be generalizable to diverse environments and tasks. Although the recently emerged foundation models (FMs) show impressive generalization power, how to effectively leverage the rich knowledge of FMs on resource-limited edge devices is still not explored. In this paper, we propose EdgeFM, a novel edge-cloud cooperative system with open-set recognition capability. EdgeFM selectively uploads unlabeled data to query the FM on the cloud and customizes the specific knowledge and architectures for edge models. Meanwhile, EdgeFM conducts dynamic model switching at run-time taking into account both data uncertainty and dynamic network variations, which ensures the accuracy always close to the original FM. We implement EdgeFM using two FMs on two edge platforms. We evaluate EdgeFM on three public datasets and two self-collected datasets. Results show that EdgeFM can reduce the end-to-end latency up to 3.2x and achieve 34.3% accuracy increase compared with the baseline.

Xiaomin Ouyang, Xian Shuai, Yang Li et al.

Alzheimer's Disease (AD) and related dementia are a growing global health challenge due to the aging population. In this paper, we present ADMarker, the first end-to-end system that integrates multi-modal sensors and new federated learning algorithms for detecting multidimensional AD digital biomarkers in natural living environments. ADMarker features a novel three-stage multi-modal federated learning architecture that can accurately detect digital biomarkers in a privacy-preserving manner. Our approach collectively addresses several major real-world challenges, such as limited data labels, data heterogeneity, and limited computing resources. We built a compact multi-modality hardware system and deployed it in a four-week clinical trial involving 91 elderly participants. The results indicate that ADMarker can accurately detect a comprehensive set of digital biomarkers with up to 93.8% accuracy and identify early AD with an average of 88.9% accuracy. ADMarker offers a new platform that can allow AD clinicians to characterize and track the complex correlation between multidimensional interpretable digital biomarkers, demographic factors of patients, and AD diagnosis in a longitudinal manner.